Strides receives USFDA approval for Ethacrynic Acid Tablets

Strides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approval for Ethacrynic Acid Tablets USP, 25 mg from the United States Food & Drug Administration (USFDA).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kfrZK2
via IFTTT